Skip to main content
. 2022 Sep 7;2022:8285084. doi: 10.1155/2022/8285084

Table 2.

Laboratory characterization of the groups (AKI(-)) and (AKI(+)).

Laboratory variable AKI(-)
n = 17
AKI(+)
n = 17
p value
Fibrinogen level (mg/dL, median (IQR)) 207.6 (203.3-207.6) 82.6 (81.5-89.6) 0.0006
Platelets (×103/mm3, median (IQR)) 229.0 (191.5-276.0) 226.0 (181.5-256.0) 0.7961
Leukocytes (×103/mm3, median (IQR)) 8.75 (7.7-9.1) 9.90 (6.5-13.8) 0.5350
Erythrocytes (×106/mm3, median (IQR)) 4.82 (4.7-5.1) 4.70 (4.3-5.2) 0.3890
Hemoglobin (g/dL, median (IQR)) 14.45 (13.9-15.4) 14.82 (12.9-15.7) 0.7304
Creatine kinase (IU/L, median (IQR)) 176.0 (106.0-242.0) 208.0 (117.5-458.5) 0.1735
Lactate dehydrogenase (IU/L, median (IQR)) 300.9 (200.1-300.2) 448.0 (346.0-707.0) 0.0005
Urea (mg/dL, median (IQR)) 32.0 (25.5-36.0) 35.0 (26.0-59.0) 0.1050
Creatinine (mg/dL, median (IQR)) 1.00 (0.90-1.25) 1.40 (1.15-1.80) 0.0036

The results are expressed as median (IQR), and the statistical analysis was performed using the Mann–Whitney test followed by the T test. Statistical significance was considered at p < 0.05 in all cases. Reference values: fibrinogen: 200-400 mg/dL; platelets: 130-400 × 103/mm3; leukocytes: 4-10 × 103/mm3; hemoglobin: 13.0-16.0 g/dL for males and 12.0-14.0 g/dL for females; creatine kinase: 24-190 IU/L; lactate dehydrogenase: 211-423 IU/L; urea: 10-45 mg/dL; creatinine: 0.5-1.2 mg/dL.